Literature DB >> 28631983

'Worse than HIV': The logics of cancer screening avoidance in Swaziland.

Nomthandazo Malambo1, Susan Erikson1.   

Abstract

This article shows the consequences of competing global health agendas within differential clinical and social worlds. Specifically, it examines how HIV's prominence in local clinical programming in Swaziland influences cervical cancer screening rates. Drawing on 2014 ethnographic research conducted in a semi-urban town in Swaziland, the interview and participant observation data show the relative scarcity of cervical cancer care and the consequences of HIV/AIDS funding and programming dominance. 20 women and 7 health workers were interviewed in homes, clinics and small businesses. Data were analysed using frameworks of medicoscapes and therapeutic citizenship. Results show that women's patterns of screening avoidance were based on lengthy diagnostic procedures, treatment expense, therapeutic travel to neighbouring South Africa, and frequent therapeutic failure. In sum, avoidance of cervical screening in Swaziland has structural components, and is a product of organisational and political choices at local and global levels. This study challenges culturalist assumptions about African women's avoidance of cervical cancer screening. In the future, delivering successful cervical cancer screening in Swaziland will depend on expanding cancer screening and treatment, which should be informed by perceptions of clinical care held by the very women public health practitioners aim to keep healthy.

Entities:  

Keywords:  Cervical cancer screening; HIV exceptionalism; Swaziland; avoidance; medicoscapes

Mesh:

Year:  2017        PMID: 28631983     DOI: 10.1080/17441692.2017.1339821

Source DB:  PubMed          Journal:  Glob Public Health        ISSN: 1744-1692


  1 in total

1.  Health system experiences of breast cancer survivors in urban South Africa.

Authors:  Madeleine Lambert; Emily Mendenhall; Andrew Wooyoung Kim; Herbert Cubasch; Maureen Joffe; Shane A Norris
Journal:  Womens Health (Lond)       Date:  2020 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.